Popular Topics & Highlights
Yesterday, Tuesday, May 24, we saw neutral social sentiment for Adaptimmune Therapeutics plc ($ADAP). We gave it a score of 7. There was little activity, such as likes and shares, on social media.
Over the prior 7 days we calculated an average sentiment score of 7 (neutral). Over the prior 14 days our AI scored an average sentiment of 5 (neutral). And for the prior 30 days our social sentiment score for Adaptimmune Therapeutics plc ($ADAP) is 2 (neutral).
We believe social network activity can help inform investors of the positive and negative opinions people hold of a company. Social media posts are made both before and after market price changes. We can make no claim of causation or future correlation between market prices and social media sentiment. We make no evaluation or predictions of stock value. We do not endorse any posts on social media which are reposted here.
This page is being provided for informational purposes only, and on the condition that it will not form a primary basis for any investment decision. Investors should make their own determination of whether or not to buy or sell a stock based on their specific investment goals, with proper due diligence, and in consultation with their financial advisor. See financial disclosures on our About the Developer page.
We've trained our artificial intelligence systems from past social media posts. While tests show our predictions are usually accurate to our models, a human may come to a different conclusion for some posts.